Key result
Personalized cardiac modeling shows promise for non-invasive sudden cardiac death risk stratification post-MI.
Why the study?
Current clinical risk stratification for sudden cardiac death in post-myocardial infarction ischemic cardiomyopathy relies on single functional indices with limited predictive accuracy, leading to challenges in implantable cardioverter-defibrillator use.
Does personalized cardiac modeling and simulation improve the prediction and risk stratification of sudden cardiac death from malignant arrhythmias in patients with post-myocardial infarction ischemic cardiomyopathy?
Does personalized cardiac modeling and simulation improve the prediction and risk stratification of sudden cardiac death from malignant arrhythmias in patients with post-myocardial infarction ischemic cardiomyopathy?
Personalized cardiac modeling utilizing multi-modal imaging offers a highly promising, non-invasive solution to improve sudden cardiac death risk stratification and optimize prophylactic implantable cardioverter-defibrillator application in post-MI patients.
Sudden cardiac death (SCD) represents a major global public health challenge, with malignant ventricular arrhythmias being its primary cause. This review focuses specifically on post-myocardial infarction (post-MI) ischemic cardiomyopathy—the most prevalent substrate for malignant ventricular arrhythmias. Current clinical practice predominantly relies on single functional indices, such as left ventricular ejection fraction, for risk stratification. This approach suffers from significant limitations in predictive accuracy, leading to dilemmas in the prophylactic application of implantable cardioverter-defibrillators, including both under-implantation and over-implantation. Personalized cardiac modeling and simulation technology, an advanced embodiment of the digital twin concept in cardiovascular medicine, offers a highly promising non-invasive solution to overcome these limitations. The core of this technology lies in the deep integration of personalized, multi-modal clinical imaging data, particularly late gadolinium enhancement sequences from cardiac magnetic resonance imaging. This enables the precise construction of individualized cardiac anatomical substrates that reflect the spatial distribution of myocardial fibrosis and scar. Building upon this anatomical foundation, multi-scale computational models are established, spanning from microscopic ion channel kinetics and cellular electrophysiological activity to macroscopic tissue conduction properties. These models systematically simulate core pro-arrhythmic factors under pathological conditions, including key ion channel remodeling, the coupling effects of non-myocytes, and alterations in anisotropic conduction properties of myocardial tissue. Ultimately, by implementing programmed electrical stimulation protocols on the computational heart model, the susceptibility to arrhythmias is dynamically assessed, achieving quantitative and visual stratification of an individual's SCD risk. This technological framework not only non-invasively reveals the dynamic electrical instability underlying static anatomical substrates but also demonstrates broad application prospects in understanding complex arrhythmia mechanisms, assisting in clinical therapeutic decision-making, and advancing the shift towards precision medicine models.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a review in Sudden cardiac death post-myocardial infarction. Personalized cardiac modeling and simulation vs. Traditional clinical practice (e.g., LVEF, ECG, EPS) was evaluated. Personalized cardiac modeling and simulation offers a promising non-invasive framework to overcome current clinical limitations in stratifying sudden cardiac death risk in post-myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: